Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast. ...
Vous n'êtes pas connecté
Clinical stage biotechnology company PharmAust has received commitments to raise $10 million via an institutional placement with directors and management subscribing for $1 million worth of shares. The cash will be used to finalise preparations for an adaptive Phase 2/3 STRIKE study in patients with Motor Neurone Disease (MND) of the drug monepantel. Monepantel is… The post PharmAust raises cash for anti-cancer study appeared first on Australian Manufacturing Forum.
Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast. ...
Additive manufacturer Amaero International has completed an upsized institutional placement to raise $25 million following strong support from...
Clinical-stage biotech PharmAust has submitted a request for orphan medicinal product designation (OMPD) to the European Medicines Agency (EMA) for...
NEW YORK (AP) — Breanna Stewart lost her father-in-law, Josep Xargay, to cancer nearly a year ago. Stewart is now helping raise awareness for the...
SpiceJet has settled its $16.7 million dispute with Engine Lease Finance Corporation for an undisclosed lower amount. The airline raised Rs. 3000...
Spear REIT has successfully completed an equity capital raise of R457.75 million via a vendor consideration placement. The vendor consideration...
Completion of $3.02M Placement Carbonxt Group Ltd (“Carbonxt” or the “Company”) (ASX: CG1) is pleased to advise that it has received firm...
MONDAY, Sept. 23, 2024 -- The incidence of a composite cardiovascular disease (CVD) end point is increased among older adults with cancer, especially...
Torque Metals has received firm commitments from sophisticated and professional investors to raise $3.1 million via a placement at 8c ...
October is Breast Cancer Awareness Month, an annual campaign to increase awareness of the disease and to raise funds for research into its cause,...